Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma.

ClinicalTrials.gov ID: NCT05288504

Public ClinicalTrials.gov record NCT05288504. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma

Study identification

NCT ID
NCT05288504
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Avalo Therapeutics, Inc.
Industry
Enrollment
91 participants

Conditions and interventions

Interventions

  • AVTX-002 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 23, 2022
Primary completion
May 10, 2023
Completion
May 10, 2023
Last update posted
Sep 4, 2024

2022 – 2023

United States locations

U.S. sites
24
U.S. states
14
U.S. cities
23
Facility City State ZIP Site status
Tucson Neuroscience Research - M3, Wake Research Tucson Arizona 85710
Center For Clinical Trials of Sacramento Sacramento California 95823
Allergy and Asthma Medical Group of the Bay Area Walnut Creek California 94598
Center For Clinical Trials of San Gabriel West Covina California 91790-3402
IMMUNOe Research Centers Centennial Colorado 80112
National Jewish Health Denver Colorado 80206
Helix Biomedics, LLC Boynton Beach Florida 33435
Suncoast Research Group LLC Miami Florida 33135
Suncoast Research Associates LLC Miami Florida 33137
Pro-Care Research Center, Corp. Miami Gardens Florida 33014
Innovation Medical Research Center Palmetto Bay Florida 33157
ASHA Clinical Research-Munster, LLC Hammond Indiana 46324
Family Allergy and Asthma Research Institute Louisville Kentucky 40215
Continental Clinical Solutions, LLC Towson Maryland 21212
Pulmonary Research Institute of Southeast Michigan Farmington Hills Michigan 48336
Midwest Clinical Research St Louis Missouri 63141
Meridian Clinical Research Lincoln Nebraska 68510
OK Clinical Research Edmond Oklahoma 73034
Affinity Health Nashville Tennessee 37203
Amarillo Center For Clinical Research Amarillo Texas 79124
South Texas Medical Research Institute, Inc Boerne Texas 78006
Pioneer Research Solutions Houston Texas 77099
Meridian Clinical Research Portsmouth Virginia 23703
Clinical Research Partners, LLC Richmond Virginia 23226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05288504, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 4, 2024 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05288504 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →